JNJ Johnson & Johnson
45,481
$151.27
$2.13
(1.39%)
| Watchers | 45,481 |
| 52-Wk Low | $143.13 |
| 52-Wk High | $175.97 |
| Market Cap | $364.06B |
| Volume | 9,048.00 |
| 52-Wk High | $175.97 |
| 52-Wk Low | $143.13 |
Inquiry Into Johnson & Johnson's Competitor Dynamics In Pharmaceuticals IndustryBenzinga • about 22 hours ago
read more...
Share to Feed
Johnson & Johnson (NYSE: JNJ) announced today that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for...
"They Left Us No Choice": Woman With Vaccine Injury In Clinical Trial Sues AstraZeneca
Authored by Zachary Stieber via The Epoch Times (emphasis ours),
A vial of AstraZeneca vaccine is...
Mayor Johnson Deepens Concerns About What Side He Will Be On If DNC Protesters Become Lawbreakers And Challenge Cops
By Mark Glennon of Wirepoints
Whose side will Chicago Mayor Brandon...
Kenvue, the maker of popular consumer health brands like Tylenol and Listerine, announced Monday that Johnson & Johnson is selling its remaining stake in the company. The reversal comes about a year...
Johnson & Johnson's Megadyne Mega Soft Pediatric Patient Return Electrodes recalled due to patient burns. FDA's Class I recall impacts 21,200 devices.
read more...
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Shockwave Medical, Inc. (NasdaqGS: SWAV) to...
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion...
A Deep Dive Into The Opioid Crisis
Authored by Matt Bivens, M.D. via Racket News,
Editor's note: the following is the first essay in a series, written by former Moscow Times co-worker...